Dr Sophie Kellaway - 2023 Leukaemia UK John Goldman Fellow

Dr Sophie Kellaway, University of Nottingham is a Leukaemia UK John Goldman Fellow for 2023. She tells us about her research project investigating how different types of RUNX1 mutation drive AML and how this could better inform treatment decisions.
Our John Goldman Fellowships were created in honour of Professor John Goldman (1938 - 2013), a renowned haematologist and pioneer in the treatment of leukaemia. These prestigious awards are aimed at early career researchers with a passion for science, a desire to develop new ideas and translate scientific advances into clinical practice.
Read about Dr Kellaway's research: www.leukaemiau...